The OECD’s latest edition of Health at a Glance shows that all countries could provide better health care.
Use the interactive world map to choose key health indicators from Health at a Glance 2009.
English, , 287kb
The aim of these guidelines is to propose a harmonised approach for the collection and analysis of biotechnology research and development (R&D) statistics in the government and higher education sectors.
This paper reports on the progress in the research and development of the set of patient safety indicators developed by the Health Care Quality Indicators project.
Overweight and obesity rates have been increasing relentlessly over recent decades in all industrialised countries, as well as in many lower income countries.
English, , 280kb
This presentation was given by Valérie Paris, Administrator, Health Division, OECD, at the Forum Économie Santé 2009, Les Échos Conférences, on 18 November 2009.
This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testin
In this report we present an assessment of public health strategies designed to tackle behavioural risk factors for chronic diseases that are closely linked with obesity, including aspects of diet and physical inactivity, in Brazil, China, India, Mexico, Russia, and South Africa.
The ability to effectively use these vast amounts of knowledge will depend in part on the bringing together of different strands of information, data and biological materials within human biobanks and genetic research databases (HBGRDs).
This report report examines selected policies that may help countries better achieve the goal of improved health system efficiency and thus better value for money.